Real-time enrollment status for this diabetes mellitus, type 2 clinical trial
Current Status
Recruiting
Checked: October 24, 2026 at 10:58 PM UTC
| NCT Number | NCT07282613 |
| Recruiting Status | Recruiting |
| Condition | Diabetes Mellitus, Type 2 |
| Phase | PHASE3 |
| Target Enrollment | 80 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Novo Nordisk A/S |
| Last Updated on CT.gov | October 19, 2026 (5 days ago) |
As of October 24, 2026: Clinical trial NCT07282613 is currently recruiting participants. This phase3 study for diabetes mellitus, type 2 is actively seeking new participants at 21 locations across the United States. The study is sponsored by Novo Nordisk A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07282613 is actively recruiting participants as of October 24, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07282613 was last updated 5 days ago (October 19, 2026). HelloStudys verifies this status automatically.